Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Here's Why Investors Should Retain Stericycle (SRCL) Stock

Published 05/28/2018, 10:14 PM
Updated 07/09/2023, 06:31 AM

A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions.

Here we focus on Stericycle, Inc. (NASDAQ:SRCL) , a stock with an expected long-term earnings per share growth rate of 9.6%. Its earnings are expected to register 6.7% and 3.4% growth, respectively, in 2018 and 2019.

The company has outperformed its industry in the past three months. The stock has soared 2.1% against the industry’s gain of 1.1%.

We believe the stock has the potential to continue the bull run. The reasons behind our optimism include the company’s strategic acquisitions, organic growth coupled with similar prudent business moves.

Let’s discuss them in detail.

Strategic Acquisitions

Stericycle continues to grow on the back of acquisitions in both domestic and international markets. In 2017 and 2016, Stericycle completed 30 and 31 acquisitions, respectively. Further, acquisitions contributed 570.1 million to 2016 revenues and $32.2 million to 2017 revenues. For first-quarter 2018, the contribution from buyouts was $7.1 million.

Stericycle is highly optimistic about “tuck-in” acquisition opportunities, which are expected to create value for shareholders and widen its services suite. In first-quarter 2018, Stericycle closed nine tuck-in acquisitions (all in the domestic market, with eight in Secure Information Destruction and one in Regulated Medical Waste). The deals together contributed about $0.7 million to corporate revenues, with estimated annualized revenues of $8.5 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The acquisition pool of the company remains robust in multiple geographies and lines of business. The global acquisition strategy increases Stericycle’s customer base by providing a long-term growth platform for selling multiple services. The company is continuously on the lookout for strategic acquisitions that will grow its market share and expand its geographic base.

Organic Growth

We appreciate Stericycle’s continuous focus on its internal development initiatives. To better meet customer demands, the company has been improving its solution offerings and platforms. This has helped Stericycle built a strong and loyal customer base along with a revenue retention rate of nearly 90%. With the help of these strong client relationships, Stericycle is trying to grow by selling additional services to the existing ones, while securing new customers. In 2017 and 2016,organic growth contributed $20.1 million and $94.6 million to total revenues, respectively.

Other Strategic Business Moves

By providing business-to-business services in highly regulated areas, Stericycle intends to help customers and businesses comply with tough regulatory policies. It mainly targets smaller businesses with high demand for regulatory assistance compared to larger businesses due to the lack of specialized staff. To this end, Stericycle is offering services, depending on the varying customer needs. We believe this business strategy will help the company earn profits as well as expand into additional service offerings like hazardous or pharmaceutical waste management, communication services and secure information destruction.

Moreover, government regulatory bodies require proper and immediate implementation of rules and regulations, trying to protect the overall health environment. This is a major positive for Stericycle, which is focused on providing regulated business-to-business services.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bottom Line

The aforementioned factors positively impacted Stericycle’s performance in the last reported quarter. In fact, the company outperformed the Zacks Consensus Estimate in two of the trailing four quarters, delivering an average positive surprise of 0.8%. We believe the upbeat performance will continue in the quarters ahead, thus giving investors enough reasons to remain optimistic on the stock.

Zacks Rank & Stocks to Consider

Currently, Stericycle has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Some better-ranked stocks in the broader Business Services sector include Waste Connections, Inc. (NYSE:WCN) , Accenture plc (NYSE:ACN) and NV5 Global (NASDAQ:NVEE) . All the stocks carry a Zacks Rank #2 (Buy).

The long-term expected earnings per share growth rates for Waste Connections, Accenture and NV5 Global are 13.3%, 10% and 20%, respectively.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Accenture PLC (ACN): Free Stock Analysis Report

NV5 Global, Inc. (NVEE): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Stericycle, Inc. (SRCL): Free Stock Analysis Report

Waste Connections, Inc. (WCN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.